ACADIA PHARMACEUTICALS INC. (ACAD) /

The revenue of ACADIA PHARMACEUTICALS INC. over the past 10 years

Chart ACADIA PHARMACEUTICALS INC.: revenue, fiscal 2016–2025 Open the chart →

ACADIA PHARMACEUTICALS INC. reported revenue of $1.07B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $17.33M — up 6083% over 9 years. Year over year, revenue rose every year. The largest one-year move was in fiscal 2017: up 621%, from $17.33M to $124.9M.

Year by year

Fiscal yearRevenue
2025ended Dec 31, 2025$1.07B
2024ended Dec 31, 2024$957.8M
2023ended Dec 31, 2023$726.44M
2022ended Dec 31, 2022$517.24M
2021ended Dec 31, 2021$484.14M
2020ended Dec 31, 2020$441.75M
2019ended Dec 31, 2019$339.08M
2018ended Dec 31, 2018$223.81M
2017ended Dec 31, 2017$124.9M
2016ended Dec 31, 2016$17.33M

Fiscal years as ACADIA PHARMACEUTICALS INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on ACADIA PHARMACEUTICALS INC.

Companies of a similar size

Not investment advice. This page shows what ACADIA PHARMACEUTICALS INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.